These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29072660)

  • 1. [The role of a leukotriene receptor antagonist in the restoration of the nasal breathing in the patients presenting with polypous rhinosinusitis].
    Mashkova TA; Mal'tsev AB; Nerovny AI; Bakulina LS
    Vestn Otorinolaringol; 2017; 82(5):32-35. PubMed ID: 29072660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of leukotriene and its receptors in eosinophilic chronic rhinosinusitis with nasal polyps.
    Wu X; Hong H; Zuo K; Han M; Li J; Wen W; Xu G; Miao B; Li H
    Int Forum Allergy Rhinol; 2016 Jan; 6(1):75-81. PubMed ID: 26332237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is montelukast indicated for treatment of chronic rhinosinusitis with polyposis?
    Smith TL; Sautter NB
    Laryngoscope; 2014 Aug; 124(8):1735-6. PubMed ID: 24338615
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the efficacy of KOB03, ketotifen, and montelukast in an experimental mouse model of allergic rhinitis.
    Jung HW; Jung JK; Park YK
    Int Immunopharmacol; 2013 Jun; 16(2):254-60. PubMed ID: 23643816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The state of the serotonin system in the patients presenting with chronic polypous rhinosinusitis].
    Shishkin AA; Karakulova YV; Voronchikhina NV
    Vestn Otorinolaringol; 2017; 82(6):15-17. PubMed ID: 29260775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of leukotriene receptor antagonism in the postoperative management of chronic rhinosinusitis.
    Yelverton JC; Holmes TW; Johnson CM; Gelves CR; Kountakis SE
    Int Forum Allergy Rhinol; 2016 Mar; 6(3):243-7. PubMed ID: 26834076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The dependence of Toll-receptor expression on pathomorphological features of nasal polyps in patients with polypous rhinosinusitis].
    Davudova BKh; Saidov MZ; Daĭkhes NA; Klimova SV; Budikhina AS; Nazhmudinov II
    Vestn Otorinolaringol; 2010; (3):32-6. PubMed ID: 20559249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis.
    Schäper C; Noga O; Koch B; Ewert R; Felix SB; Gläser S; Kunkel G; Gustavus B
    J Investig Allergol Clin Immunol; 2011; 21(1):51-8. PubMed ID: 21370724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and cellular staging for the severity of chronic rhinosinusitis.
    Kountakis SE; Arango P; Bradley D; Wade ZK; Borish L
    Laryngoscope; 2004 Nov; 114(11):1895-905. PubMed ID: 15510011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois.
    Tan BK; Klingler AI; Poposki JA; Stevens WW; Peters AT; Suh LA; Norton J; Carter RG; Hulse KE; Harris KE; Grammer LC; Schleimer RP; Welch KC; Smith SS; Conley DB; Kern RC; Kato A
    J Allergy Clin Immunol; 2017 Feb; 139(2):699-703.e7. PubMed ID: 27639939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peculiar features of immunological and metabolic status associated with polypous rhinosinusitis].
    Kolenchukova OA; Smirnova SV; Lapteva AM
    Vestn Otorinolaringol; 2015; 80(6):22-27. PubMed ID: 26978747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Some immunologic indices in patients with chronic polypous rhinosinusitis].
    Iarlykov SA; Shagova VS; Iarlykov AS
    Vestn Otorinolaringol; 1993; (5-6):20-2. PubMed ID: 8009764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of leukotriene receptor antagonist therapy in patients with chronic rhinosinusitis in a real life rhinology clinic setting.
    Wilson AM; White PS; Gardiner Q; Nassif R; Lipworth BJ
    Rhinology; 2001 Sep; 39(3):142-6. PubMed ID: 11721504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential synergistic effects of novel hematopoietic prostaglandin D synthase inhibitor TAS-205 and different types of anti-allergic medicine on nasal obstruction in a Guinea pig model of experimental allergic rhinitis.
    Aoyagi H; Kajiwara D; Tsunekuni K; Tanaka K; Miyoshi K; Hirasawa N
    Eur J Pharmacol; 2020 May; 875():173030. PubMed ID: 32084417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis and clinical features of polypous rhinosinusitis].
    Trofimenko SL
    Vestn Otorinolaringol; 2010; (4):94-7. PubMed ID: 21105357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant activity of histamine and cysteinyl leukotrienes on porcine nasal mucosal vessels and nasal inflammation in the rat.
    Lieber G; Jimenez J; Hunter JC; McLeod RL; Jia Y
    Pharmacology; 2010; 85(5):311-8. PubMed ID: 20453555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibodies to staphylococcal autostrains in polypoid tissue of the human nasal mucosa].
    Lebedev KA; Turchaninova GD; Kostrova IN
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Mar; (3):89-92. PubMed ID: 7415675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polypous rhinosinusitis in the context of the asthma triad].
    Tsyvkina AA; Tsarev SV
    Vestn Otorinolaringol; 2011; (1):77-80. PubMed ID: 21378746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic rhinosinusitis--need for further classification?
    Rudack C; Sachse F; Alberty J
    Inflamm Res; 2004 Mar; 53(3):111-7. PubMed ID: 15021966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desloratadine-montelukast combination improves quality of life and decreases nasal obstruction in patients with perennial allergic rhinitis.
    Cingi C; Oghan F; Eskiizmir G; Yaz A; Ural A; Erdogmus N
    Int Forum Allergy Rhinol; 2013 Oct; 3(10):801-6. PubMed ID: 23733270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.